Your browser doesn't support javascript.
loading
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study.
Qi, Shu-Nan; Yang, Yong; Zhang, Yu-Jing; Huang, Hui-Qiang; Wang, Ying; He, Xia; Zhang, Li-Ling; Wu, Gang; Qu, Bao-Lin; Qian, Li-Ting; Hou, Xiao-Rong; Zhang, Fu-Quan; Qiao, Xue-Ying; Wang, Hua; Li, Gao-Feng; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Xu, Li-Ming; Yuan, Zhi-Yong; Su, Hang; Song, Yu-Qin; Zhu, Jun; Hu, Chen; Li, Ye-Xiong.
Afiliación
  • Qi SN; Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China.
  • Yang Y; Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China.
  • Zhang YJ; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Huang HQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, China.
  • Wang Y; Department of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Hospital, Chongqing, China.
  • He X; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.
  • Zhang LL; Department of Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wu G; Department of Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Qu BL; Department of Radiation Oncology, The General Hospital of Chinese People's Liberation Army, Beijing, China.
  • Qian LT; Department of Radiation Oncology, The Affiliated Provincial Hospital of Anhui Medical University, Hefei, China.
  • Hou XR; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China.
  • Zhang FQ; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China.
  • Qiao XY; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Wang H; Department of Radiation Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Li GF; Department of Radiation Oncology, Beijing Hospital, National Geriatric Medical Center, Beijing, China.
  • Zhu Y; Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
  • Cao JZ; Department of Radiation Oncology, Shanxi Cancer Hospital and the Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan, China.
  • Wu JX; Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Fuzhou, China.
  • Wu T; Department of Radiation Oncology, Affiliated Hospital of Guizhou Medical University, Guizhou Cancer Hospital, Guiyang, China.
  • Zhu SY; Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China.
  • Shi M; Department of Radiation Oncology, Xijing Hospital of Fourth Military Medical University, Xi'an, China.
  • Xu LM; Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
  • Yuan ZY; Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
  • Su H; Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
  • Song YQ; Department of Medical Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.
  • Zhu J; Department of Medical Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.
  • Hu C; Division of Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Li YX; Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China.
Am J Hematol ; 95(9): 1047-1056, 2020 09.
Article en En | MEDLINE | ID: mdl-32449800
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Extranodal de Células NK-T / Quimioradioterapia Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Am J Hematol Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Extranodal de Células NK-T / Quimioradioterapia Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Am J Hematol Año: 2020 Tipo del documento: Article País de afiliación: China